Compare REVG & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REVG | LGND |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | 2017 | 1992 |
| Metric | REVG | LGND |
|---|---|---|
| Price | $67.74 | $192.99 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $48.00 | ★ $243.50 |
| AVG Volume (30 Days) | ★ 527.4K | 226.9K |
| Earning Date | 03-04-2026 | 02-26-2026 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | N/A | ★ 0.76 |
| EPS | 1.89 | ★ 2.49 |
| Revenue | ★ $2,463,500,000.00 | $251,233,000.00 |
| Revenue This Year | $9.52 | $47.71 |
| Revenue Next Year | $7.89 | $9.77 |
| P/E Ratio | ★ $36.27 | $78.74 |
| Revenue Growth | 3.50 | ★ 64.83 |
| 52 Week Low | $26.51 | $93.58 |
| 52 Week High | $69.52 | $212.49 |
| Indicator | REVG | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 70.63 | 49.06 |
| Support Level | $66.73 | $175.89 |
| Resistance Level | $69.52 | $199.35 |
| Average True Range (ATR) | 1.75 | 8.40 |
| MACD | 0.21 | -0.12 |
| Stochastic Oscillator | 80.41 | 55.00 |
REV Group Inc is a U.S.-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services, operating through two segments: Specialty Vehicles and Recreational Vehicles. The Specialty Vehicles segment includes fire apparatus, ambulances, terminal trucks, and sweepers sold under brands such as E-One, Ferrara, KME, Spartan ER, AEV, Horton, Leader, Road Rescue, Wheeled Coach, Capacity, and LayMor. The Recreational Vehicles segment includes American Coach, Fleetwood RV, Holiday Rambler, Renegade RV, and Midwest Automotive Designs, offering Class A, B, C, and Super C motorized RVs and products from Goldshield Fiberglass. The majority of revenue is generated from the Specialty Vehicles segment.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.